D&D Pharmatek widened its losses in the Nextrade (NXT) aftermarket after the regular trading session closed on the 22nd, falling below the psychologically significant 100,000-won level.

In the regular market that day, D&D Pharmatek closed at 107,500 won, down 3,700 won (3.33%) from the previous trading day. However, in the NXT aftermarket conducted after market close, the stock was trading at 99,900 won as of 5:06 p.m. On an NXT basis, this represents a decline of 11,300 won (10.16%) from the previous day's closing price.

Meanwhile, D&D Pharmatek announced through a conversion claim exercise disclosure filed that day that 29.9 billion won worth of its 1st unsecured private perpetual subordinated convertible bonds with warrants would be converted into 1,423,762 common shares. The number of newly issued shares from the conversion accounts for 3.21% of the total existing issued shares, with a scheduled listing date of July 9. Based on the disclosure, the remaining balance of unconverted convertible bonds is approximately 4.04 billion won, and the number of shares eligible for additional future conversion is 209,489 shares.

Future changes in supply and demand as well as the direction of investor sentiment remain to be seen.

[This article is in no way intended to solicit investment. The content may represent mere opinions, so please do not use it as a reference or material for investment. All investment decisions are made at the discretion of the individual, and the final responsibility lies with the investor. This publication assumes no liability whatsoever.]